Kelly Gajewski, MD
Pediatric Cardiology · New Orleans, LANPI 1356421739
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,317 of the $2,048 with a category attached, or 64.3%. Abbott accounts for 91.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,467 and has fallen 95.9% since, to $61 in 2025.
Across 25 payments — averaging $81.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$61
- Philips North America LLC$44
- Sarepta Therapeutics, Inc.$20
- Bardy Diagnostics, Inc.$15
- Silvergate Pharmaceuticals, Inc.$15
- plus $12 from 1 others
What the payments were for
- Travel & lodging$1,31764%
- Food & beverage$73136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $1,881 |
| Boston Scientific | 2 | $61 |
| Philips North America LLC | 2 | $44 |
| Sarepta Therapeutics, Inc. | 1 | $20 |
| Bardy Diagnostics, Inc. | 2 | $15 |
| Silvergate Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$1,308
How this compares
$2,048 in reported general payments places this provider in the 85th percentile of 38 pediatric cardiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enalapril Maleate | 13 | $119 |
| Amiodarone Hcl | 12 | $71 |
| Furosemide | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other pediatric cardiology in New Orleans
- Ivory CrittendonNew Orleans$35K
- Michael WeilandNew Orleans$5K
- Alexandru FiranNew Orleans$3K
- Minghua HaoNew Orleans$1K
- Shannon PowellNew Orleans$1K
- Thomas YoungNew Orleans$341
- Diego LaraNew Orleans$336
- Tamara BradfordNew Orleans$251
- Kamill del ToroNew Orleans$231
- Jessica MouledouxNew Orleans$228
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.